Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 6548
TargetPyruvate kinase PKM(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandChemical structure of BindingDB Monomer ID 82190BDBM82190(Salicylic acid derivative, compound 2)
Affinity DataIC50: 7.00E+3nMAssay Description:Primary screening was performed using PKM2 in the presence of FBP. Compounds were chosen as potential "hits" if the compound demonstrated inhibition ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2015
Entry Details
US Patent

TargetPyruvate kinase PKM(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandChemical structure of BindingDB Monomer ID 138386BDBM138386(US8877791, B1)
Affinity DataIC50: 1.00E+4nMAssay Description:Primary screening was performed using PKM2 in the presence of FBP. Compounds were chosen as potential "hits" if the compound demonstrated inhibition ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2015
Entry Details
US Patent

TargetPyruvate kinase PKM(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandChemical structure of BindingDB Monomer ID 50261993BDBM50261993(5-(methylthio)thiophene-2-carboxylic acid | CHEMBL...)
Affinity DataIC50: 1.00E+4nMAssay Description:Primary screening was performed using PKM2 in the presence of FBP. Compounds were chosen as potential "hits" if the compound demonstrated inhibition ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2015
Entry Details
US Patent

TargetPyruvate kinase PKM(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandChemical structure of BindingDB Monomer ID 138387BDBM138387(US8877791, D1)
Affinity DataIC50: 2.00E+4nMAssay Description:Primary screening was performed using PKM2 in the presence of FBP. Compounds were chosen as potential "hits" if the compound demonstrated inhibition ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2015
Entry Details
US Patent

TargetPyruvate kinase PKM(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandChemical structure of BindingDB Monomer ID 138388BDBM138388(US8877791, G1)
Affinity DataIC50: 7.00E+4nMAssay Description:Primary screening was performed using PKM2 in the presence of FBP. Compounds were chosen as potential "hits" if the compound demonstrated inhibition ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2015
Entry Details
US Patent

TargetPyruvate kinase PKM(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandChemical structure of BindingDB Monomer ID 138385BDBM138385(US8877791, A1)
Affinity DataIC50: 9.00E+4nMAssay Description:Primary screening was performed using PKM2 in the presence of FBP. Compounds were chosen as potential "hits" if the compound demonstrated inhibition ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2015
Entry Details
US Patent

TargetPyruvate kinase PKM(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandChemical structure of BindingDB Monomer ID 138389BDBM138389(US8877791, H1)
Affinity DataIC50: 9.00E+4nMAssay Description:Primary screening was performed using PKM2 in the presence of FBP. Compounds were chosen as potential "hits" if the compound demonstrated inhibition ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2015
Entry Details
US Patent

TargetPyruvate kinase PKM(Human)
Beth Israel Deaconess Medical Center

US Patent
LigandChemical structure of BindingDB Monomer ID 11995BDBM11995(2-chloro-5-(2,5-dimethyl-1H-pyrrol-1-yl)benzoic ac...)
Affinity DataIC50: 1.00E+5nMAssay Description:Primary screening was performed using PKM2 in the presence of FBP. Compounds were chosen as potential "hits" if the compound demonstrated inhibition ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2015
Entry Details
US Patent